<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:316eb9bf-eb12-40d1-909c-2d6fa4ebf1cf,g:49ad4c01-2558-485d-a84f-a89fdd6d14fb,d:56fec9cbc7db44d6ad3cd7019f6aaf00--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdxg-20230613</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF80L2ZyYWc6YWFjZDhkMTAyZTE1NGU1NjhlOGUzNDk0NTVkNDhkMzEvdGFibGU6NTVlNjlmY2IxNWE0NDY4OThkNDE3YTVhN2E4NDg2ZDQvdGFibGVyYW5nZTo1NWU2OWZjYjE1YTQ0Njg5OGQ0MTdhNWE3YTg0ODZkNF8yLTEtMS0xLTE2NDEzNg_264ba255-cea5-4b6e-90f5-71ab116126cc">0001376339</ix:nonNumeric><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF80L2ZyYWc6YWFjZDhkMTAyZTE1NGU1NjhlOGUzNDk0NTVkNDhkMzEvdGFibGU6NTVlNjlmY2IxNWE0NDY4OThkNDE3YTVhN2E4NDg2ZDQvdGFibGVyYW5nZTo1NWU2OWZjYjE1YTQ0Njg5OGQ0MTdhNWE3YTg0ODZkNF80LTEtMS0xLTE2NDEzNg_bbb462db-3792-4987-afe0-467b9cf5aa5a">false</ix:nonNumeric><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF80L2ZyYWc6YWFjZDhkMTAyZTE1NGU1NjhlOGUzNDk0NTVkNDhkMzEvdGFibGU6NTVlNjlmY2IxNWE0NDY4OThkNDE3YTVhN2E4NDg2ZDQvdGFibGVyYW5nZTo1NWU2OWZjYjE1YTQ0Njg5OGQ0MTdhNWE3YTg0ODZkNF83LTEtMS0xLTE2NDE3NQ_7c9ccd3d-91fd-4744-b352-cdd06230e755">--12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdxg-20230613.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-13</xbrli:startDate><xbrli:endDate>2023-06-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i56fec9cbc7db44d6ad3cd7019f6aaf00_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDA3_9eefce69-a06c-4fe1-9d2e-ae8f18339dca">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M18yNjY_3a11906e-b1b5-48f4-bc0c-39f7c547a00a">June 13, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDA4_9a9c6e67-14a2-4e50-92be-32e188d478c7">MIMEDX GROUP, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.539%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.305%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6Y2MwNGEyMWNmN2NmNGE3OTk4ZmE5NTU5NzMyNDJmZTYvdGFibGVyYW5nZTpjYzA0YTIxY2Y3Y2Y0YTc5OThmYTk1NTk3MzI0MmZlNl8wLTAtMS0xLTE2NDEzNg_2d3f7880-8c7a-49bf-a478-4169adcfa1a9">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6Y2MwNGEyMWNmN2NmNGE3OTk4ZmE5NTU5NzMyNDJmZTYvdGFibGVyYW5nZTpjYzA0YTIxY2Y3Y2Y0YTc5OThmYTk1NTk3MzI0MmZlNl8wLTItMS0xLTE2NDEzNg_184caf28-4ef3-4897-a86e-d1eb6cdfac73">001-35887</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6Y2MwNGEyMWNmN2NmNGE3OTk4ZmE5NTU5NzMyNDJmZTYvdGFibGVyYW5nZTpjYzA0YTIxY2Y3Y2Y0YTc5OThmYTk1NTk3MzI0MmZlNl8wLTQtMS0xLTE2NDEzNg_903f1aeb-e403-444e-adde-fb188f623c93">26-2792552</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Commission</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDEy_368e107e-c33d-48e6-abff-625188844171">1775 West Oak Commons Ct., NE</ix:nonNumeric>, <ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDA5_0d1f3447-428e-4ad8-afc7-b0d086ce9d1b">Marietta</ix:nonNumeric> <ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDEw_0b28b6c3-c041-4e23-b26b-fdf9c916ca09">GA</ix:nonNumeric> <ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDEz_77da9e6e-93a9-4b6d-8fd2-b3435140fe95">30062</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDEx_6a47acfc-9a37-4ed4-aa18-9e5625c96e8b">770</ix:nonNumeric>) <ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDE0_0773fa32-6da3-4a65-90e8-f73682c8ae9e">651-9100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:0.1%"></td><td style="width:2.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6Y2EwODhhNmM0ODc5NDNmOGEwYTc2MjdlMWZiYzVlYWQvdGFibGVyYW5nZTpjYTA4OGE2YzQ4Nzk0M2Y4YTBhNzYyN2UxZmJjNWVhZF8wLTAtMS0xLTE2NDEzNg_253e9c7f-3f93-4590-ae1c-3f7e5286e742">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6Y2EwODhhNmM0ODc5NDNmOGEwYTc2MjdlMWZiYzVlYWQvdGFibGVyYW5nZTpjYTA4OGE2YzQ4Nzk0M2Y4YTBhNzYyN2UxZmJjNWVhZF8xLTAtMS0xLTE2NDEzNg_7bdbf665-2db1-4baf-8098-acea2be36f92">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6Y2EwODhhNmM0ODc5NDNmOGEwYTc2MjdlMWZiYzVlYWQvdGFibGVyYW5nZTpjYTA4OGE2YzQ4Nzk0M2Y4YTBhNzYyN2UxZmJjNWVhZF8yLTAtMS0xLTE2NDEzNg_170fc6c9-4828-49c6-95aa-c53833bb1421">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6Y2EwODhhNmM0ODc5NDNmOGEwYTc2MjdlMWZiYzVlYWQvdGFibGVyYW5nZTpjYTA4OGE2YzQ4Nzk0M2Y4YTBhNzYyN2UxZmJjNWVhZF8zLTAtMS0xLTE2NDEzNg_db58ef94-df22-420a-b27a-4d1a3d294ab6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"></td><td style="width:27.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6NDc1NTNjMDA1MDA1NDg3NWJiZmJjMDNhYWQ5ZTc1YmUvdGFibGVyYW5nZTo0NzU1M2MwMDUwMDU0ODc1YmJmYmMwM2FhZDllNzViZV8xLTAtMS0xLTE2NDEzNg_af98cdc8-7033-419d-bb63-2ddc77f069d8">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6NDc1NTNjMDA1MDA1NDg3NWJiZmJjMDNhYWQ5ZTc1YmUvdGFibGVyYW5nZTo0NzU1M2MwMDUwMDU0ODc1YmJmYmMwM2FhZDllNzViZV8xLTItMS0xLTE2NDEzNg_8a7a4249-c38d-46c2-948d-33c31f1a2e14">MDXG</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGFibGU6NDc1NTNjMDA1MDA1NDg3NWJiZmJjMDNhYWQ5ZTc1YmUvdGFibGVyYW5nZTo0NzU1M2MwMDUwMDU0ODc1YmJmYmMwM2FhZDllNzViZV8xLTQtMS0xLTE2NDEzNg_353306f5-e907-4768-850b-54c6e10ece73">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic0e276f159864e5dbc1261c89371dd3e_D20230613-20230613" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2ZmVjOWNiYzdkYjQ0ZDZhZDNjZDcwMTlmNmFhZjAwL3NlYzo1NmZlYzljYmM3ZGI0NGQ2YWQzY2Q3MDE5ZjZhYWYwMF8xL2ZyYWc6ZDhmNjAyMGIzMDk5NGQwYjg4NjEzMzFlMzlhMTVhOTMvdGV4dHJlZ2lvbjpkOGY2MDIwYjMwOTk0ZDBiODg2MTMzMWUzOWExNWE5M181NDE1_92797ce4-b85a-42cb-83a1-a3604ffdbf8a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">    </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-58.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 5.02             Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 13, 2023, the shareholders of MiMedx Group, Inc. (the &#8220;Company&#8221;) authorized the amendment and restatement of the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (the &#8220;2016 Plan&#8221;) at the Company&#8217;s 2023 Annual Meeting (as defined in Item 5.07 of this Current Report on Form 8-K (this &#8220;Report&#8221;). A description of the material terms of the 2016 Plan, as amended and restated (the &#8220;Amended 2016 Plan&#8221;) was included on pages 52-63 of the Company&#8217;s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on May 15, 2023, which description is incorporated herein by reference. The description of the Amended 2016 Plan is qualified in its entirety by reference to the actual terms of the plan, which is attached to this Current Report on Form 8-K as Exhibit 10.1.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.03             Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 13, 2023, the shareholders of the Company approved an amendment to the Company&#8217;s Restated Articles of Incorporation, as amended (the &#8220;Articles of Amendment&#8221;), to increase the number of authorized shares of the Company&#8217;s common stock from 187,500,000 shares ($.001 par value) to 250,000,000 shares ($.001 par value). A description of the material terms of the Articles of Amendment was included on pages 50-51 of the Company&#8217;s definitive proxy statement on Schedule 14A filed with the SEC on May 15, 2023, which description is incorporated herein by reference. Following approval by the Company&#8217;s shareholders, the Company filed the Articles of Amendment with the Secretary of State of the State of Florida, and the Articles of Amendment became effective on June 14, 2023. The Articles of Amendment are filed as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.07             Submission of Matters to a Vote of Security Holders.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 13, 2023, the Company held its 2023 Annual Meeting of shareholders (the &#8220;2023 Annual Meeting&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At the 2023 Annual Meeting, shares of Company common stock and Series B Convertible Preferred Stock representing 105,075,876 votes (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, approximately 78.07% of votes entitled to be cast at the 2023 Annual Meeting) were represented in person or by proxy.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At the 2023 Annual Meeting, the shareholders: (1) re-elected James L. Bierman, Dr. Phyllis L. Gardner, Dr. Michael Giuliani, and Dr. Cato Laurencin; (2) approved an advisory resolution regarding executive compensation; (3) ratified the appointment of Deloitte &amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2023; (4) approved the Articles of Amendment to increase the number of shares of authorized common stock from 187,500,000 to 250,000,000 as described in Item 5.03 of this Report; and (5) approved the Amended 2016 Plan as described in Item 5.02 of this Report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Set forth below is information regarding the votes cast for each proposal:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Proposal 1: Election of Four Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:18.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18.75pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Broker Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">James L. Bierman</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">69,547,312</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,616,025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,290,449</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28,622,090</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Phyllis I. Gardner</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">65,275,355</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9,955,824</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,222,607</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28,622,090</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Michael Giuliani</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">69,820,124</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,294,598</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,339,064</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28,622,090</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Cato Laurencin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">70,620,287</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,107,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">725,767</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28,622,090</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Proposal 2: Advisory approval of executive compensation.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:8.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Broker Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Shares Voted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">67,923,704</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8,341,327</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">188,755</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28,622,090</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Proposal 3: Ratification of Deloitte &amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2023.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"></td><td style="width:8.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Broker Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Shares Voted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">102,019,286</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3,003,085</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">53,505</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">N/A</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Proposal 4: Approval of Amendment to the Company's Restated Articles of Incorporation, as Amended.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:9.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Broker Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Shares Voted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">84,539,487</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">19,771,042</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">765,437</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">N/A</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Proposal 5: Approval of an Amendment and Restatement of the Company's 2016 Equity and Cash Incentive Plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.005%"><tr><td style="width:1.0%"></td><td style="width:8.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Broker Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Shares Voted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">58,162,435</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">17,000,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,290,540</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;text-indent:1.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28,622,090</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;Financial Statements and Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31-articlesofincorporati.htm">Articles of Amendment to Restated Articles of Incorporation, as Amended</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-mimedxxar2016equitya.htm">Amended and Restated 2016 Equity and Cash Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="padding-left:4.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:42.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MIMEDX GROUP, INC.</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 14, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William &#8220;Butch&#8221; Hulse</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William &#8220;Butch&#8221; Hulse<br/>General Counsel &amp; Chief Administrative Officer<br/></span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "mdxg-20230613.htm", "description": "8-K", "secsgml_size_bytes": 63188}]
{"company-data": {"conformed-name": "MIMEDX GROUP, INC.", "cik": "0001376339", "assigned-sic": "3841", "irs-number": "262792552", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35887", "film-number": "231014416"}, "business-address": {"street1": "1775 W OAK COMMONS COURT, NE", "city": "MARIETTA", "state": "GA", "zip": "30062", "phone": "(770) 651-9100"}, "mail-address": {"street1": "1775 W OAK COMMONS COURT, NE", "city": "MARIETTA", "state": "GA", "zip": "30062"}, "former-company": {"former-conformed-name": "Alynx, Co.", "date-changed": "20060922"}}
mdxg-20230613
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________
FORM
8-K
____________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
June 13, 2023
MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
Florida
001-35887
26-2792552
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
1775 West Oak Commons Ct., NE
,
Marietta
GA
30062
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (
770
)
651-9100
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.001 par value per share
MDXG
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02             Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 13, 2023, the shareholders of MiMedx Group, Inc. (the "Company") authorized the amendment and restatement of the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (the "2016 Plan") at the Company's 2023 Annual Meeting (as defined in Item 5.07 of this Current Report on Form 8-K (this "Report"). A description of the material terms of the 2016 Plan, as amended and restated (the "Amended 2016 Plan") was included on pages 52-63 of the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission ("SEC") on May 15, 2023, which description is incorporated herein by reference. The description of the Amended 2016 Plan is qualified in its entirety by reference to the actual terms of the plan, which is attached to this Current Report on Form 8-K as Exhibit 10.1.
Item 5.03             Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On June 13, 2023, the shareholders of the Company approved an amendment to the Company's Restated Articles of Incorporation, as amended (the "Articles of Amendment"), to increase the number of authorized shares of the Company's common stock from 187,500,000 shares ($.001 par value) to 250,000,000 shares ($.001 par value). A description of the material terms of the Articles of Amendment was included on pages 50-51 of the Company's definitive proxy statement on Schedule 14A filed with the SEC on May 15, 2023, which description is incorporated herein by reference. Following approval by the Company's shareholders, the Company filed the Articles of Amendment with the Secretary of State of the State of Florida, and the Articles of Amendment became effective on June 14, 2023. The Articles of Amendment are filed as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated herein by reference.
Item 5.07             Submission of Matters to a Vote of Security Holders.
On June 13, 2023, the Company held its 2023 Annual Meeting of shareholders (the "2023 Annual Meeting").
At the 2023 Annual Meeting, shares of Company common stock and Series B Convertible Preferred Stock representing 105,075,876 votes (
i.e.
, approximately 78.07% of votes entitled to be cast at the 2023 Annual Meeting) were represented in person or by proxy.
At the 2023 Annual Meeting, the shareholders: (1) re-elected James L. Bierman, Dr. Phyllis L. Gardner, Dr. Michael Giuliani, and Dr. Cato Laurencin; (2) approved an advisory resolution regarding executive compensation; (3) ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023; (4) approved the Articles of Amendment to increase the number of shares of authorized common stock from 187,500,000 to 250,000,000 as described in Item 5.03 of this Report; and (5) approved the Amended 2016 Plan as described in Item 5.02 of this Report.
Set forth below is information regarding the votes cast for each proposal:
Proposal 1: Election of Four Directors.
For
Against
Abstain
Broker Non-votes
James L. Bierman
69,547,312
5,616,025
1,290,449
28,622,090
Dr. Phyllis I. Gardner
65,275,355
9,955,824
1,222,607
28,622,090
Dr. Michael Giuliani
69,820,124
5,294,598
1,339,064
28,622,090
Dr. Cato Laurencin
70,620,287
5,107,732
725,767
28,622,090
Proposal 2: Advisory approval of executive compensation.
For
Against
Abstain
Broker Non-votes
Total Shares Voted
67,923,704
8,341,327
188,755
28,622,090
Proposal 3: Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.
For
Against
Abstain
Broker Non-votes
Total Shares Voted
102,019,286
3,003,085
53,505
N/A
Proposal 4: Approval of Amendment to the Company's Restated Articles of Incorporation, as Amended.
For
Against
Abstain
Broker Non-votes
Total Shares Voted
84,539,487
19,771,042
765,437
N/A
Proposal 5: Approval of an Amendment and Restatement of the Company's 2016 Equity and Cash Incentive Plan.
For
Against
Abstain
Broker Non-votes
Total Shares Voted
58,162,435
17,000,811
1,290,540
28,622,090
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description of Exhibit
3.1
Articles of Amendment to Restated Articles of Incorporation, as Amended
.
10.1
Amended and Restated 2016 Equity and Cash Incentive Plan.
104
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MIMEDX GROUP, INC.
June 14, 2023
By:
/s/ William "Butch" Hulse
William "Butch" Hulse
General Counsel & Chief Administrative Officer